Solstice Oncology, Inc.

Biotechnology company · Boston, Massachusetts, United States

Solstice Oncology, Inc. is a biotechnology company headquartered in Boston, Massachusetts, United States. Its earliest recorded incorporation is in 2026. It has reported private securities offerings to the US SEC, most recently $121 million sold in a notice filed in 2026.

Profile compiled from public records. Is this your company? Request a correction or update

Solstice Oncology at a glance

Typebiotechnology company

HeadquartersBoston, Massachusetts, United States

Earliest incorporation on record2026

SEC CIK2116600

What does Solstice Oncology do?

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $121.3 million sold (2026).

Frequently asked questions about Solstice Oncology

Where is Solstice Oncology headquartered?

Solstice Oncology, Inc. is headquartered in Boston, Massachusetts, United States.

What does Solstice Oncology do?

Solstice Oncology, Inc. is a biotechnology company.

When was Solstice Oncology founded?

The earliest incorporation on record for Solstice Oncology, Inc. is in 2026, according to public company registers.

Similar companies

Syntis Bio, Inc.Boston, Massachusetts, United States
Strand Therapeutics Inc.Boston, Massachusetts, United States
Pear Therapeutics, Inc.Boston, Massachusetts, United States
Aura Biosciences, Inc.Boston, Massachusetts, United States
Holobiome, Inc.Boston, Massachusetts, United States
Leuko Labs, Inc.Boston, Massachusetts, United States
Compass Therapeutics, Inc.Boston, Massachusetts, United States
Odyssey Therapeutics, Inc.Boston, Massachusetts, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences